0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human BMP-2 Market Research Report 2026
Published Date: 2026-01-26
|
Report Code: QYRE-Auto-16U18581
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human BMP 2 Market Research Report 2024
BUY CHAPTERS

Global Recombinant Human BMP-2 Market Research Report 2026

Code: QYRE-Auto-16U18581
Report
2026-01-26
Pages:132
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Recombinant Human BMP-2 Market Size

The global Recombinant Human BMP-2 market was valued at US$ 2371 million in 2025 and is anticipated to reach US$ 2869 million by 2032, at a CAGR of 2.8% from 2026 to 2032.

Recombinant Human BMP-2 Market

Recombinant Human BMP-2 Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Recombinant Human BMP-2 competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Recombinant Human BMP-2 is a protein produced by genetic engineering, which has the biological activity of promoting bone growth and repair. It is characterized by its ability to effectively induce the differentiation of osteocytes and the formation of bone tissue, and has high biocompatibility and safety. Its advantages are that it can reduce the need for traditional bone transplantation, reduce the risk of surgical complications, accelerate the bone healing process, and improve treatment efficiency. As an innovative biomaterial, it shows great application potential and clinical value in orthopedic surgery and bone tissue engineering.
The North American market for Recombinant Human BMP-2 is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Recombinant Human BMP-2 is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Recombinant Human BMP-2 include Thermo Fisher, Proteintech, Sigma Aldrich, Cgbio, Cell Guidance Systems, Biomol GmbH, STEMCELL Technologies, CUSABIO TECHNOLOGY, Shanghai NovoPro, Shanghai Zhong Qiao Xin Zhou Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Recombinant Human BMP-2 market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Recombinant Human BMP-2. The Recombinant Human BMP-2 market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Recombinant Human BMP-2 market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Recombinant Human BMP-2 manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Recombinant Human BMP-2 Market Report

Report Metric Details
Report Name Recombinant Human BMP-2 Market
Accounted market size in 2025 US$ 2371 million
Forecasted market size in 2032 US$ 2869 million
CAGR 2.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Powder
  • Sponge
  • Others
by Application
  • Hospital
  • Research Institute
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher, Proteintech, Sigma Aldrich, Cgbio, Cell Guidance Systems, Biomol GmbH, STEMCELL Technologies, CUSABIO TECHNOLOGY, Shanghai NovoPro, Shanghai Zhong Qiao Xin Zhou Biotechnology, HANGZHOU JIUYUAN GENE ENGINEERIN, Yantai Zhenghai Bio-Tech, Yeasen Biotechnology (Shanghai), WEIGAO, Abbkine Scientific, Beijing Baiaolaibo Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Recombinant Human BMP-2 manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Recombinant Human BMP-2 sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Recombinant Human BMP-2 Market growing?

Ans: The Recombinant Human BMP-2 Market witnessing a CAGR of 2.8% during the forecast period 2026-2032.

What is the Recombinant Human BMP-2 Market size in 2032?

Ans: The Recombinant Human BMP-2 Market size in 2032 will be US$ 2869 million.

Who are the main players in the Recombinant Human BMP-2 Market report?

Ans: The main players in the Recombinant Human BMP-2 Market are Thermo Fisher, Proteintech, Sigma Aldrich, Cgbio, Cell Guidance Systems, Biomol GmbH, STEMCELL Technologies, CUSABIO TECHNOLOGY, Shanghai NovoPro, Shanghai Zhong Qiao Xin Zhou Biotechnology, HANGZHOU JIUYUAN GENE ENGINEERIN, Yantai Zhenghai Bio-Tech, Yeasen Biotechnology (Shanghai), WEIGAO, Abbkine Scientific, Beijing Baiaolaibo Technology

What are the Application segmentation covered in the Recombinant Human BMP-2 Market report?

Ans: The Applications covered in the Recombinant Human BMP-2 Market report are Hospital, Research Institute, Others

What are the Type segmentation covered in the Recombinant Human BMP-2 Market report?

Ans: The Types covered in the Recombinant Human BMP-2 Market report are Powder, Sponge, Others

1 Recombinant Human BMP-2 Market Overview
1.1 Product Definition
1.2 Recombinant Human BMP-2 by Type
1.2.1 Global Recombinant Human BMP-2 Market Value by Type: 2025 vs 2032
1.2.2 Powder
1.2.3 Sponge
1.2.4 Others
1.3 Recombinant Human BMP-2 by Application
1.3.1 Global Recombinant Human BMP-2 Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Global Recombinant Human BMP-2 Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human BMP-2 Revenue 2021–2032
1.4.2 Global Recombinant Human BMP-2 Sales 2021–2032
1.4.3 Global Recombinant Human BMP-2 Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Recombinant Human BMP-2 Market Competition by Manufacturers
2.1 Global Recombinant Human BMP-2 Sales Market Share by Manufacturers (2021–2026)
2.2 Global Recombinant Human BMP-2 Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Recombinant Human BMP-2 Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Recombinant Human BMP-2, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Recombinant Human BMP-2, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Recombinant Human BMP-2, Product Types and Applications
2.7 Global Key Manufacturers of Recombinant Human BMP-2, Date of Entry into the Industry
2.8 Global Recombinant Human BMP-2 Market Competitive Situation and Trends
2.8.1 Global Recombinant Human BMP-2 Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Recombinant Human BMP-2 Players Market Share by Revenue
2.8.3 Global Recombinant Human BMP-2 Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human BMP-2 Market Scenario by Region
3.1 Global Recombinant Human BMP-2 Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Recombinant Human BMP-2 Sales by Region: 2021–2032
3.2.1 Global Recombinant Human BMP-2 Sales by Region: 2021–2026
3.2.2 Global Recombinant Human BMP-2 Sales by Region: 2027–2032
3.3 Global Recombinant Human BMP-2 Revenue by Region: 2021–2032
3.3.1 Global Recombinant Human BMP-2 Revenue by Region: 2021–2026
3.3.2 Global Recombinant Human BMP-2 Revenue by Region: 2027–2032
3.4 North America Recombinant Human BMP-2 Market Facts & Figures by Country
3.4.1 North America Recombinant Human BMP-2 Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Recombinant Human BMP-2 Sales by Country (2021–2032)
3.4.3 North America Recombinant Human BMP-2 Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human BMP-2 Market Facts & Figures by Country
3.5.1 Europe Recombinant Human BMP-2 Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Recombinant Human BMP-2 Sales by Country (2021–2032)
3.5.3 Europe Recombinant Human BMP-2 Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human BMP-2 Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human BMP-2 Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Recombinant Human BMP-2 Sales by Region (2021–2032)
3.6.3 Asia Pacific Recombinant Human BMP-2 Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human BMP-2 Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human BMP-2 Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Recombinant Human BMP-2 Sales by Country (2021–2032)
3.7.3 Latin America Recombinant Human BMP-2 Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Human BMP-2 Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human BMP-2 Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Recombinant Human BMP-2 Sales by Country (2021–2032)
3.8.3 Middle East and Africa Recombinant Human BMP-2 Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human BMP-2 Sales by Type (2021–2032)
4.1.1 Global Recombinant Human BMP-2 Sales by Type (2021–2026)
4.1.2 Global Recombinant Human BMP-2 Sales by Type (2027–2032)
4.1.3 Global Recombinant Human BMP-2 Sales Market Share by Type (2021–2032)
4.2 Global Recombinant Human BMP-2 Revenue by Type (2021–2032)
4.2.1 Global Recombinant Human BMP-2 Revenue by Type (2021–2026)
4.2.2 Global Recombinant Human BMP-2 Revenue by Type (2027–2032)
4.2.3 Global Recombinant Human BMP-2 Revenue Market Share by Type (2021–2032)
4.3 Global Recombinant Human BMP-2 Price by Type (2021–2032)
5 Segment by Application
5.1 Global Recombinant Human BMP-2 Sales by Application (2021–2032)
5.1.1 Global Recombinant Human BMP-2 Sales by Application (2021–2026)
5.1.2 Global Recombinant Human BMP-2 Sales by Application (2027–2032)
5.1.3 Global Recombinant Human BMP-2 Sales Market Share by Application (2021–2032)
5.2 Global Recombinant Human BMP-2 Revenue by Application (2021–2032)
5.2.1 Global Recombinant Human BMP-2 Revenue by Application (2021–2026)
5.2.2 Global Recombinant Human BMP-2 Revenue by Application (2027–2032)
5.2.3 Global Recombinant Human BMP-2 Revenue Market Share by Application (2021–2032)
5.3 Global Recombinant Human BMP-2 Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Recombinant Human BMP-2 Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Proteintech
6.2.1 Proteintech Company Information
6.2.2 Proteintech Description and Business Overview
6.2.3 Proteintech Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Proteintech Recombinant Human BMP-2 Product Portfolio
6.2.5 Proteintech Recent Developments/Updates
6.3 Sigma Aldrich
6.3.1 Sigma Aldrich Company Information
6.3.2 Sigma Aldrich Description and Business Overview
6.3.3 Sigma Aldrich Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sigma Aldrich Recombinant Human BMP-2 Product Portfolio
6.3.5 Sigma Aldrich Recent Developments/Updates
6.4 Cgbio
6.4.1 Cgbio Company Information
6.4.2 Cgbio Description and Business Overview
6.4.3 Cgbio Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Cgbio Recombinant Human BMP-2 Product Portfolio
6.4.5 Cgbio Recent Developments/Updates
6.5 Cell Guidance Systems
6.5.1 Cell Guidance Systems Company Information
6.5.2 Cell Guidance Systems Description and Business Overview
6.5.3 Cell Guidance Systems Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cell Guidance Systems Recombinant Human BMP-2 Product Portfolio
6.5.5 Cell Guidance Systems Recent Developments/Updates
6.6 Biomol GmbH
6.6.1 Biomol GmbH Company Information
6.6.2 Biomol GmbH Description and Business Overview
6.6.3 Biomol GmbH Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Biomol GmbH Recombinant Human BMP-2 Product Portfolio
6.6.5 Biomol GmbH Recent Developments/Updates
6.7 STEMCELL Technologies
6.7.1 STEMCELL Technologies Company Information
6.7.2 STEMCELL Technologies Description and Business Overview
6.7.3 STEMCELL Technologies Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 STEMCELL Technologies Recombinant Human BMP-2 Product Portfolio
6.7.5 STEMCELL Technologies Recent Developments/Updates
6.8 CUSABIO TECHNOLOGY
6.8.1 CUSABIO TECHNOLOGY Company Information
6.8.2 CUSABIO TECHNOLOGY Description and Business Overview
6.8.3 CUSABIO TECHNOLOGY Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CUSABIO TECHNOLOGY Recombinant Human BMP-2 Product Portfolio
6.8.5 CUSABIO TECHNOLOGY Recent Developments/Updates
6.9 Shanghai NovoPro
6.9.1 Shanghai NovoPro Company Information
6.9.2 Shanghai NovoPro Description and Business Overview
6.9.3 Shanghai NovoPro Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Shanghai NovoPro Recombinant Human BMP-2 Product Portfolio
6.9.5 Shanghai NovoPro Recent Developments/Updates
6.10 Shanghai Zhong Qiao Xin Zhou Biotechnology
6.10.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
6.10.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Description and Business Overview
6.10.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Product Portfolio
6.10.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments/Updates
6.11 HANGZHOU JIUYUAN GENE ENGINEERIN
6.11.1 HANGZHOU JIUYUAN GENE ENGINEERIN Company Information
6.11.2 HANGZHOU JIUYUAN GENE ENGINEERIN Description and Business Overview
6.11.3 HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Product Portfolio
6.11.5 HANGZHOU JIUYUAN GENE ENGINEERIN Recent Developments/Updates
6.12 Yantai Zhenghai Bio-Tech
6.12.1 Yantai Zhenghai Bio-Tech Company Information
6.12.2 Yantai Zhenghai Bio-Tech Description and Business Overview
6.12.3 Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Product Portfolio
6.12.5 Yantai Zhenghai Bio-Tech Recent Developments/Updates
6.13 Yeasen Biotechnology (Shanghai)
6.13.1 Yeasen Biotechnology (Shanghai) Company Information
6.13.2 Yeasen Biotechnology (Shanghai) Description and Business Overview
6.13.3 Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Product Portfolio
6.13.5 Yeasen Biotechnology (Shanghai) Recent Developments/Updates
6.14 WEIGAO
6.14.1 WEIGAO Company Information
6.14.2 WEIGAO Description and Business Overview
6.14.3 WEIGAO Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 WEIGAO Recombinant Human BMP-2 Product Portfolio
6.14.5 WEIGAO Recent Developments/Updates
6.15 Abbkine Scientific
6.15.1 Abbkine Scientific Company Information
6.15.2 Abbkine Scientific Description and Business Overview
6.15.3 Abbkine Scientific Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Abbkine Scientific Recombinant Human BMP-2 Product Portfolio
6.15.5 Abbkine Scientific Recent Developments/Updates
6.16 Beijing Baiaolaibo Technology
6.16.1 Beijing Baiaolaibo Technology Company Information
6.16.2 Beijing Baiaolaibo Technology Description and Business Overview
6.16.3 Beijing Baiaolaibo Technology Recombinant Human BMP-2 Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Beijing Baiaolaibo Technology Recombinant Human BMP-2 Product Portfolio
6.16.5 Beijing Baiaolaibo Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human BMP-2 Industry Chain Analysis
7.2 Recombinant Human BMP-2 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human BMP-2 Production Mode & Process Analysis
7.4 Recombinant Human BMP-2 Sales and Marketing
7.4.1 Recombinant Human BMP-2 Sales Channels
7.4.2 Recombinant Human BMP-2 Distributors
7.5 Recombinant Human BMP-2 Customer Analysis
8 Recombinant Human BMP-2 Market Dynamics
8.1 Recombinant Human BMP-2 Industry Trends
8.2 Recombinant Human BMP-2 Market Drivers
8.3 Recombinant Human BMP-2 Market Challenges
8.4 Recombinant Human BMP-2 Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Recombinant Human BMP-2 Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Recombinant Human BMP-2 Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Recombinant Human BMP-2 Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Recombinant Human BMP-2 Sales (kg) of Key Manufacturers (2021–2026)
 Table 5. Global Recombinant Human BMP-2 Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Recombinant Human BMP-2 Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Recombinant Human BMP-2 Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Recombinant Human BMP-2 Average Price (US$/g) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Recombinant Human BMP-2, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Recombinant Human BMP-2, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Recombinant Human BMP-2, Product Types and Applications
 Table 12. Global Key Manufacturers of Recombinant Human BMP-2, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Human BMP-2 Companies by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Human BMP-2 Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Human BMP-2 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Recombinant Human BMP-2 Sales by Region (kg), 2021–2026
 Table 18. Global Recombinant Human BMP-2 Sales Market Share by Region (2021–2026)
 Table 19. Global Recombinant Human BMP-2 Sales by Region (kg), 2027–2032
 Table 20. Global Recombinant Human BMP-2 Sales Market Share by Region (2027–2032)
 Table 21. Global Recombinant Human BMP-2 Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Recombinant Human BMP-2 Revenue Market Share by Region (2021–2026)
 Table 23. Global Recombinant Human BMP-2 Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Recombinant Human BMP-2 Revenue Market Share by Region (2027–2032)
 Table 25. North America Recombinant Human BMP-2 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Recombinant Human BMP-2 Sales by Country (kg), 2021–2026
 Table 27. North America Recombinant Human BMP-2 Sales by Country (kg), 2027–2032
 Table 28. North America Recombinant Human BMP-2 Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Recombinant Human BMP-2 Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Recombinant Human BMP-2 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Recombinant Human BMP-2 Sales by Country (kg), 2021–2026
 Table 32. Europe Recombinant Human BMP-2 Sales by Country (kg), 2027–2032
 Table 33. Europe Recombinant Human BMP-2 Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Recombinant Human BMP-2 Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Recombinant Human BMP-2 Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Recombinant Human BMP-2 Sales by Region (kg), 2021–2026
 Table 37. Asia Pacific Recombinant Human BMP-2 Sales by Region (kg), 2027–2032
 Table 38. Asia Pacific Recombinant Human BMP-2 Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Recombinant Human BMP-2 Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Recombinant Human BMP-2 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Recombinant Human BMP-2 Sales by Country (kg), 2021–2026
 Table 42. Latin America Recombinant Human BMP-2 Sales by Country (kg), 2027–2032
 Table 43. Latin America Recombinant Human BMP-2 Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Recombinant Human BMP-2 Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Recombinant Human BMP-2 Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Recombinant Human BMP-2 Sales by Country (kg), 2021–2026
 Table 47. Middle East and Africa Recombinant Human BMP-2 Sales by Country (kg), 2027–2032
 Table 48. Middle East and Africa Recombinant Human BMP-2 Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Recombinant Human BMP-2 Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Recombinant Human BMP-2 Sales (kg) by Type (2021–2026)
 Table 51. Global Recombinant Human BMP-2 Sales (kg) by Type (2027–2032)
 Table 52. Global Recombinant Human BMP-2 Sales Market Share by Type (2021–2026)
 Table 53. Global Recombinant Human BMP-2 Sales Market Share by Type (2027–2032)
 Table 54. Global Recombinant Human BMP-2 Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Recombinant Human BMP-2 Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Recombinant Human BMP-2 Revenue Market Share by Type (2021–2026)
 Table 57. Global Recombinant Human BMP-2 Revenue Market Share by Type (2027–2032)
 Table 58. Global Recombinant Human BMP-2 Price (US$/g) by Type (2021–2026)
 Table 59. Global Recombinant Human BMP-2 Price (US$/g) by Type (2027–2032)
 Table 60. Global Recombinant Human BMP-2 Sales (kg) by Application (2021–2026)
 Table 61. Global Recombinant Human BMP-2 Sales (kg) by Application (2027–2032)
 Table 62. Global Recombinant Human BMP-2 Sales Market Share by Application (2021–2026)
 Table 63. Global Recombinant Human BMP-2 Sales Market Share by Application (2027–2032)
 Table 64. Global Recombinant Human BMP-2 Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Recombinant Human BMP-2 Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Recombinant Human BMP-2 Revenue Market Share by Application (2021–2026)
 Table 67. Global Recombinant Human BMP-2 Revenue Market Share by Application (2027–2032)
 Table 68. Global Recombinant Human BMP-2 Price (US$/g) by Application (2021–2026)
 Table 69. Global Recombinant Human BMP-2 Price (US$/g) by Application (2027–2032)
 Table 70. Thermo Fisher Company Information
 Table 71. Thermo Fisher Description and Business Overview
 Table 72. Thermo Fisher Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 73. Thermo Fisher Recombinant Human BMP-2 Product
 Table 74. Thermo Fisher Recent Developments/Updates
 Table 75. Proteintech Company Information
 Table 76. Proteintech Description and Business Overview
 Table 77. Proteintech Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 78. Proteintech Recombinant Human BMP-2 Product
 Table 79. Proteintech Recent Developments/Updates
 Table 80. Sigma Aldrich Company Information
 Table 81. Sigma Aldrich Description and Business Overview
 Table 82. Sigma Aldrich Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 83. Sigma Aldrich Recombinant Human BMP-2 Product
 Table 84. Sigma Aldrich Recent Developments/Updates
 Table 85. Cgbio Company Information
 Table 86. Cgbio Description and Business Overview
 Table 87. Cgbio Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 88. Cgbio Recombinant Human BMP-2 Product
 Table 89. Cgbio Recent Developments/Updates
 Table 90. Cell Guidance Systems Company Information
 Table 91. Cell Guidance Systems Description and Business Overview
 Table 92. Cell Guidance Systems Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 93. Cell Guidance Systems Recombinant Human BMP-2 Product
 Table 94. Cell Guidance Systems Recent Developments/Updates
 Table 95. Biomol GmbH Company Information
 Table 96. Biomol GmbH Description and Business Overview
 Table 97. Biomol GmbH Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 98. Biomol GmbH Recombinant Human BMP-2 Product
 Table 99. Biomol GmbH Recent Developments/Updates
 Table 100. STEMCELL Technologies Company Information
 Table 101. STEMCELL Technologies Description and Business Overview
 Table 102. STEMCELL Technologies Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 103. STEMCELL Technologies Recombinant Human BMP-2 Product
 Table 104. STEMCELL Technologies Recent Developments/Updates
 Table 105. CUSABIO TECHNOLOGY Company Information
 Table 106. CUSABIO TECHNOLOGY Description and Business Overview
 Table 107. CUSABIO TECHNOLOGY Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 108. CUSABIO TECHNOLOGY Recombinant Human BMP-2 Product
 Table 109. CUSABIO TECHNOLOGY Recent Developments/Updates
 Table 110. Shanghai NovoPro Company Information
 Table 111. Shanghai NovoPro Description and Business Overview
 Table 112. Shanghai NovoPro Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 113. Shanghai NovoPro Recombinant Human BMP-2 Product
 Table 114. Shanghai NovoPro Recent Developments/Updates
 Table 115. Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
 Table 116. Shanghai Zhong Qiao Xin Zhou Biotechnology Description and Business Overview
 Table 117. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 118. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Product
 Table 119. Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments/Updates
 Table 120. HANGZHOU JIUYUAN GENE ENGINEERIN Company Information
 Table 121. HANGZHOU JIUYUAN GENE ENGINEERIN Description and Business Overview
 Table 122. HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 123. HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Product
 Table 124. HANGZHOU JIUYUAN GENE ENGINEERIN Recent Developments/Updates
 Table 125. Yantai Zhenghai Bio-Tech Company Information
 Table 126. Yantai Zhenghai Bio-Tech Description and Business Overview
 Table 127. Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 128. Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Product
 Table 129. Yantai Zhenghai Bio-Tech Recent Developments/Updates
 Table 130. Yeasen Biotechnology (Shanghai) Company Information
 Table 131. Yeasen Biotechnology (Shanghai) Description and Business Overview
 Table 132. Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 133. Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Product
 Table 134. Yeasen Biotechnology (Shanghai) Recent Developments/Updates
 Table 135. WEIGAO Company Information
 Table 136. WEIGAO Description and Business Overview
 Table 137. WEIGAO Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 138. WEIGAO Recombinant Human BMP-2 Product
 Table 139. WEIGAO Recent Developments/Updates
 Table 140. Abbkine Scientific Company Information
 Table 141. Abbkine Scientific Description and Business Overview
 Table 142. Abbkine Scientific Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 143. Abbkine Scientific Recombinant Human BMP-2 Product
 Table 144. Abbkine Scientific Recent Developments/Updates
 Table 145. Beijing Baiaolaibo Technology Company Information
 Table 146. Beijing Baiaolaibo Technology Description and Business Overview
 Table 147. Beijing Baiaolaibo Technology Recombinant Human BMP-2 Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 148. Beijing Baiaolaibo Technology Recombinant Human BMP-2 Product
 Table 149. Beijing Baiaolaibo Technology Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Recombinant Human BMP-2 Distributors List
 Table 153. Recombinant Human BMP-2 Customers List
 Table 154. Recombinant Human BMP-2 Market Trends
 Table 155. Recombinant Human BMP-2 Market Drivers
 Table 156. Recombinant Human BMP-2 Market Challenges
 Table 157. Recombinant Human BMP-2 Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Human BMP-2
 Figure 2. Global Recombinant Human BMP-2 Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Recombinant Human BMP-2 Market Share by Type: 2025 & 2032
 Figure 4. Powder Product Picture
 Figure 5. Sponge Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Recombinant Human BMP-2 Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Recombinant Human BMP-2 Market Share by Application: 2025 & 2032
 Figure 9. Hospital
 Figure 10. Research Institute
 Figure 11. Others
 Figure 12. Global Recombinant Human BMP-2 Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Recombinant Human BMP-2 Market Size (US$ Million), 2021–2032
 Figure 14. Global Recombinant Human BMP-2 Sales (kg), 2021–2032
 Figure 15. Global Recombinant Human BMP-2 Average Price (US$/g), 2021–2032
 Figure 16. Recombinant Human BMP-2 Report Years Considered
 Figure 17. Recombinant Human BMP-2 Sales Share by Manufacturers in 2025
 Figure 18. Global Recombinant Human BMP-2 Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Recombinant Human BMP-2 Players: Market Share by Revenue in Recombinant Human BMP-2 in 2025
 Figure 20. Recombinant Human BMP-2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Recombinant Human BMP-2 Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Recombinant Human BMP-2 Sales Market Share by Country (2021–2032)
 Figure 23. North America Recombinant Human BMP-2 Revenue Market Share by Country (2021–2032)
 Figure 24. United States Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Recombinant Human BMP-2 Sales Market Share by Country (2021–2032)
 Figure 27. Europe Recombinant Human BMP-2 Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Recombinant Human BMP-2 Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Recombinant Human BMP-2 Revenue Market Share by Region (2021–2032)
 Figure 35. China Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Recombinant Human BMP-2 Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Recombinant Human BMP-2 Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Recombinant Human BMP-2 Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Recombinant Human BMP-2 Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Recombinant Human BMP-2 Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Recombinant Human BMP-2 by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Recombinant Human BMP-2 by Type (2021–2032)
 Figure 55. Global Recombinant Human BMP-2 Price (US$/g) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Recombinant Human BMP-2 by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Recombinant Human BMP-2 by Application (2021–2032)
 Figure 58. Global Recombinant Human BMP-2 Price (US$/g) by Application (2021–2032)
 Figure 59. Recombinant Human BMP-2 Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS